€297.00
Product information
| Active substances | POLYCAPROLACTONE MICROSPHERES, CARBOXYMETHYLCELLULOSE |
|---|---|
| Manufacturer | Sinclair |
| Pack size | 2 x 1ml Pre-Filled Syringes |
| Strength | 30%, 70% |
We guarantee your order will arrive quickly. Most parcels are delivered within 5–10 business days, ensuring you get the products you need when you need them.
Enjoy personalized support with a dedicated account manager. From product selection to tracking, you’ll always have a trusted partner by your side.
Shop confidently from our selection of medical products. Each item is available for fast, reliable delivery, so your practice stays fully stocked.
We supply only authentic products, backed by full traceability. Every order comes with confidence, transparency, and assurance of verified sourcing.
ELLANSÉ™ S represents an innovative advancement in dermal filler technology, combining immediate volumizing effects with long-term collagen biostimulation. This advanced dermal filler utilizes polycaprolactone microspheres suspended in a carboxymethylcellulose gel carrier to deliver dual-action treatment for facial volume restoration and skin rejuvenation.
Medical professionals seeking to purchase ELLANSÉ S will find that this product offers superior longevity compared to traditional fillers, with results lasting approximately 12 months.
Professional administration of ELLANSÉ™ requires proper injection technique using 27G needles at mid-to-deep dermal depths. Each treatment session typically utilizes 1-2 ml of product, depending on the target area and desired correction level. The pre-filled syringe design ensures sterile, precise delivery while maintaining product integrity.
Medical professionals must follow strict aseptic protocols during administration of dermal fillers. The injection technique involves slow, controlled delivery with gentle massage to ensure optimal product distribution and dispersion. Treatment duration typically ranges from 30 to 60 minutes, depending on the areas being addressed and the complexity of the correction required.
The core composition of ELLANSÉ™ S consists of polycaprolactone microspheres (30%) suspended in a carboxymethylcellulose gel carrier (70%). These smooth, spherical microspheres measure 25-50 microns in diameter, providing optimal biocompatibility and ELLANSÉ™ S collagen stimulation properties. Additional components include phosphate-buffered saline and glycerin, all of which meet pharmaceutical grade standards.
The synthetic, non-animal-derived formulation eliminates cross-species contamination risks and reduces the potential for allergic reactions. All ingredients undergo rigorous quality control testing to ensure compliance with safety and efficacy standards.
Proper storage requires maintaining temperatures between 15°C to 25°C in controlled environments. Products must be protected from direct sunlight, freezing temperatures, and excessive heat exposure. The sterile packaging should remain intact until immediately before use, and any damaged syringes should be discarded.
Treatment contraindications include active skin infections, inflammatory conditions, autoimmune disorders, and pregnancy or breastfeeding. Patients with a tendency to form keloids or those with skin hypersensitivity require careful evaluation before treatment. Previous adverse reactions to similar fillers represent absolute contraindications.
A medical history assessment must identify any concurrent medications that may increase the risk of bleeding or interfere with the healing process. Practitioners should exercise clinical judgment when evaluating patients with compromised immune systems or ongoing medical treatments.
Healthcare providers must possess the appropriate training and licensing for administering dermal fillers. Proper injection technique is essential to avoid vascular complications, nerve damage, or unintended product placement. Emergency protocols should be established for managing adverse events.
Patients require comprehensive consultation regarding realistic expectations, potential risks, and post-treatment care requirements. The irreversible nature of ELLANSÉ™ filler necessitates careful treatment planning and conservative initial volume correction approaches.
AQTIS Medical BV manufactures ELLANSÉ™ products under ISO 13485 certification in the Netherlands. The product maintains CE-marking for European distribution and complies with Class III medical device regulations. Regulatory approval ensures safety and efficacy standards for professional dermal treatment applications.
Healthcare professionals can buy authentic ELLANSE products through licensed distributors who provide verification of lot numbers and manufacturing dates. When medical practices order ELLANSÉ™ fillers, they receive comprehensive documentation supporting regulatory compliance and professional liability requirements.
